INR vs NBIX · P/E 23, rev $356.4M vs P/E 45, rev $1.77B
Infinity Natural Resources, Inc. (INR) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Infinity Natural Resources, Inc. (INR) is a oil & gas e&p company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported INR revenue for 2025-12-31 was $356.4M. Net income was $13.8M. Revenue was up 37.6% from 2024-12-31 to 2025-12-31. INR currently screens at market cap $1.18B and trailing P/E 23.2.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
INR currently screens at market cap $1.18B and trailing P/E 23.2. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the INR and NBIX stock pages for the full models.
Not investment advice.